Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04522323
Title A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC

renal cell carcinoma


Axitinib + MEDI5752

Age Groups: senior | adult
Covered Countries USA | FRA | ESP

No variant requirements are available.